vs

Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and Healthcare Realty Trust Inc (HR). Click either name above to swap in a different company.

Healthcare Realty Trust Inc is the larger business by last-quarter revenue ($286.3M vs $270.8M, roughly 1.1× HUTCHMED (China) Ltd). Healthcare Realty Trust Inc runs the higher net margin — 183.4% vs 0.7%, a 182.7% gap on every dollar of revenue. On growth, Healthcare Realty Trust Inc posted the faster year-over-year revenue change (-7.6% vs -16.5%).

HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.

Duke Realty was a real estate investment trust (REIT) based in Indianapolis, Indiana, that invested in industrial properties. As of December 31, 2021, it owned or jointly controlled 548 primarily industrial properties containing 162.7 million rentable square feet. In October 2022, it was acquired by Prologis.

HCM vs HR — Head-to-Head

Bigger by revenue
HR
HR
1.1× larger
HR
$286.3M
$270.8M
HCM
Growing faster (revenue YoY)
HR
HR
+9.0% gap
HR
-7.6%
-16.5%
HCM
Higher net margin
HR
HR
182.7% more per $
HR
183.4%
0.7%
HCM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HCM
HCM
HR
HR
Revenue
$270.8M
$286.3M
Net Profit
$2.0M
$14.6M
Gross Margin
37.7%
Operating Margin
-13.2%
Net Margin
0.7%
183.4%
Revenue YoY
-16.5%
-7.6%
Net Profit YoY
-83.6%
113.5%
EPS (diluted)
$0.00
$0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HCM
HCM
HR
HR
Q4 25
$270.8M
$286.3M
Q3 25
$297.8M
Q2 25
$277.7M
$297.5M
Q1 25
$324.5M
$299.0M
Q4 24
$309.8M
Q3 24
$315.4M
Q2 24
$305.7M
$316.3M
Q1 24
$326.8M
Net Profit
HCM
HCM
HR
HR
Q4 25
$2.0M
$14.6M
Q3 25
$-57.7M
Q2 25
$455.0M
$-157.9M
Q1 25
$11.9M
$-44.9M
Q4 24
$-108.2M
Q3 24
$-93.0M
Q2 24
$25.8M
$-143.8M
Q1 24
$-310.8M
Gross Margin
HCM
HCM
HR
HR
Q4 25
37.7%
Q3 25
Q2 25
0.1%
Q1 25
48.0%
Q4 24
Q3 24
Q2 24
41.1%
Q1 24
Operating Margin
HCM
HCM
HR
HR
Q4 25
-13.2%
Q3 25
Q2 25
-1.3%
Q1 25
-5.0%
Q4 24
Q3 24
Q2 24
-9.0%
Q1 24
Net Margin
HCM
HCM
HR
HR
Q4 25
0.7%
183.4%
Q3 25
-19.4%
Q2 25
163.8%
-53.1%
Q1 25
3.7%
-15.0%
Q4 24
-1924.1%
Q3 24
-29.5%
Q2 24
8.4%
-45.5%
Q1 24
-95.1%
EPS (diluted)
HCM
HCM
HR
HR
Q4 25
$0.00
$0.04
Q3 25
$-0.17
Q2 25
$0.52
$-0.45
Q1 25
$0.01
$-0.13
Q4 24
$-0.34
Q3 24
$-0.26
Q2 24
$0.03
$-0.39
Q1 24
$-0.82

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HCM
HCM
HR
HR
Cash + ST InvestmentsLiquidity on hand
$1.4B
$26.2M
Total DebtLower is stronger
$93.2M
$3.9B
Stockholders' EquityBook value
$1.2B
$4.6B
Total Assets
$1.8B
$9.2B
Debt / EquityLower = less leverage
0.08×
0.85×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HCM
HCM
HR
HR
Q4 25
$1.4B
$26.2M
Q3 25
$43.3M
Q2 25
$1.4B
$25.5M
Q1 25
$836.1M
$25.7M
Q4 24
$68.9M
Q3 24
$22.8M
Q2 24
$802.5M
$41.8M
Q1 24
$26.2M
Total Debt
HCM
HCM
HR
HR
Q4 25
$93.2M
$3.9B
Q3 25
$4.5B
Q2 25
$93.4M
$4.7B
Q1 25
$82.8M
$4.7B
Q4 24
$4.7B
Q3 24
$5.0B
Q2 24
$82.1M
$5.1B
Q1 24
$5.1B
Stockholders' Equity
HCM
HCM
HR
HR
Q4 25
$1.2B
$4.6B
Q3 25
$4.7B
Q2 25
$1.2B
$4.8B
Q1 25
$759.9M
$5.1B
Q4 24
$5.2B
Q3 24
$5.5B
Q2 24
$740.1M
$5.9B
Q1 24
$6.4B
Total Assets
HCM
HCM
HR
HR
Q4 25
$1.8B
$9.2B
Q3 25
$9.9B
Q2 25
$1.8B
$10.2B
Q1 25
$1.3B
$10.5B
Q4 24
$10.7B
Q3 24
$11.2B
Q2 24
$1.3B
$11.8B
Q1 24
$12.3B
Debt / Equity
HCM
HCM
HR
HR
Q4 25
0.08×
0.85×
Q3 25
0.96×
Q2 25
0.08×
0.97×
Q1 25
0.11×
0.93×
Q4 24
0.89×
Q3 24
0.90×
Q2 24
0.11×
0.87×
Q1 24
0.80×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HCM
HCM
HR
HR
Operating Cash FlowLast quarter
$8.2M
$457.1M
Free Cash FlowOCF − Capex
$3.4M
FCF MarginFCF / Revenue
1.2%
Capex IntensityCapex / Revenue
1.8%
Cash ConversionOCF / Net Profit
4.21×
31.33×
TTM Free Cash FlowTrailing 4 quarters
$-96.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HCM
HCM
HR
HR
Q4 25
$8.2M
$457.1M
Q3 25
$113.8M
Q2 25
$-72.9M
$163.2M
Q1 25
$40.3M
$47.8M
Q4 24
$501.6M
Q3 24
$119.3M
Q2 24
$-39.8M
$168.2M
Q1 24
$76.2M
Free Cash Flow
HCM
HCM
HR
HR
Q4 25
$3.4M
Q3 25
Q2 25
$-82.2M
Q1 25
$32.5M
Q4 24
Q3 24
Q2 24
$-49.9M
Q1 24
FCF Margin
HCM
HCM
HR
HR
Q4 25
1.2%
Q3 25
Q2 25
-29.6%
Q1 25
10.0%
Q4 24
Q3 24
Q2 24
-16.3%
Q1 24
Capex Intensity
HCM
HCM
HR
HR
Q4 25
1.8%
Q3 25
Q2 25
3.3%
Q1 25
2.4%
Q4 24
Q3 24
Q2 24
3.3%
Q1 24
Cash Conversion
HCM
HCM
HR
HR
Q4 25
4.21×
31.33×
Q3 25
Q2 25
-0.16×
Q1 25
3.38×
Q4 24
Q3 24
Q2 24
-1.54×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons